LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 20.44 | 771.67 | 1677 | 1910 | 0.8776 | 0.8100 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 22.66 | 771.67 | 2344 | 2141 | 1.0946 | 1.1266 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 22.66 | 771.67 | 1800 | 2141 | 0.8405 | 0.7774 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.89 | 771.67 | 2655 | 2397 | 1.1073 | 1.1286 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.89 | 771.67 | 1968 | 2397 | 0.8208 | 0.7725 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 27.11 | 771.67 | 2907 | 2675 | 1.0867 | 1.0949 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 27.11 | 771.67 | 2177 | 2675 | 0.8138 | 0.7829 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.33 | 771.67 | 3155 | 2939 | 1.0734 | 1.0747 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.33 | 771.67 | 2412 | 2939 | 0.8206 | 0.8052 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.55 | 771.67 | 3386 | 3196 | 1.0592 | 1.0569 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.55 | 771.67 | 2620 | 3196 | 0.8196 | 0.8151 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.78 | 771.67 | 3711 | 3499 | 1.0604 | 1.0545 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.78 | 771.67 | 2800 | 3499 | 0.8001 | 0.8056 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 36.00 | 771.67 | 4152 | 3884 | 1.0688 | 1.0579 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 36.00 | 771.67 | 3050 | 3884 | 0.7851 | 0.8029 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 38.22 | 771.67 | 4501 | 4299 | 1.0468 | 1.0373 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 38.22 | 771.67 | 3304 | 4299 | 0.7684 | 0.7983 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 40.44 | 771.67 | 4866 | 4738 | 1.0269 | 1.0204 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 40.44 | 771.67 | 3564 | 4738 | 0.7522 | 0.7939 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 42.67 | 771.67 | 5171 | 5155 | 1.0030 | 1.0022 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 42.67 | 771.67 | 3916 | 5155 | 0.7595 | 0.8090 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 44.89 | 771.67 | 5593 | 5541 | 1.0093 | 1.0065 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 44.89 | 771.67 | 4113 | 5541 | 0.7422 | 0.8010 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.11 | 771.67 | 5957 | 5941 | 1.0026 | 1.0018 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.11 | 771.67 | 4467 | 5941 | 0.7518 | 0.8154 | MN20160304_L01 | M03 |